Detalhe da pesquisa
1.
Worldwide Increasing Use of Nonfasting Rather Than Fasting Lipid Profiles.
Clin Chem
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38646857
2.
Small Dense Low-Density Lipoprotein Cholesterol and Ischemic Stroke.
Ann Neurol
; 93(5): 952-964, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36606557
3.
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment.
Curr Atheroscler Rep
; 26(4): 111-118, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38311667
4.
Hypertriglyceridemia-Associated Pancreatitis: New Concepts and Potential Mechanisms.
Clin Chem
; 69(10): 1132-1144, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37530032
5.
ApoB and Non-HDL Cholesterol Versus LDL Cholesterol for Ischemic Stroke Risk.
Ann Neurol
; 92(3): 379-389, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35635038
6.
Smoking as the most important risk factor for chronic pancreatitis in the general population.
Eur J Epidemiol
; 38(1): 95-107, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36593333
7.
Lipoprotein(a) as Part of the Diagnosis of Clinical Familial Hypercholesterolemia.
Curr Atheroscler Rep
; 24(4): 289-296, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35107760
8.
A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs.
Eur Heart J
; 42(47): 4807-4817, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34455435
9.
Low lipoprotein(a) levels and risk of disease in a large, contemporary, general population study.
Eur Heart J
; 42(12): 1147-1156, 2021 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33724357
10.
Genetics of Lipoprotein(a): Cardiovascular Disease and Future Therapy.
Curr Atheroscler Rep
; 23(8): 46, 2021 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34148150
11.
Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention: A Population-Based Study.
Arterioscler Thromb Vasc Biol
; 40(1): 255-266, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31578080
12.
Low and high pancreatic amylase is associated with pancreatic cancer and chronic pancreatitis.
Eur J Epidemiol
; 36(9): 975-984, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34482515
13.
Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study.
Eur Heart J
; 41(24): 2288-2299, 2020 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32267934
14.
Lipoprotein(a): is it more, less or equal to LDL as a causal factor for cardiovascular disease and mortality?
Curr Opin Lipidol
; 31(3): 125-131, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32304380
15.
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.
Clin Chem Lab Med
; 58(4): 496-517, 2020 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31855562
16.
High lipoprotein(a) and high risk of mortality.
Eur Heart J
; 40(33): 2760-2770, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30608559
17.
Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non-gemfibrozil fibrate trials.
J Intern Med
; 295(5): 707-710, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38343109
18.
Antisense Oligonucleotides Targeting Lipoprotein(a).
Curr Atheroscler Rep
; 21(8): 30, 2019 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31111240
19.
Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting.
Eur Heart J
; 39(27): 2589-2596, 2018 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29931232
20.
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM.
Clin Chem
; 64(7): 1006-1033, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29760220